MedPage TodayNew Targets, Diseases for CAR T-Cell TherapyMedPage TodayIn quick succession this summer and fall, the FDA granted the first two approvals of CAR T-cell therapy for malignant diseases: tisagenlecleucel (Kymriah) in late August for children… Continue reading
Tech TimesThe Progress and Promise of Gene EditingMedPage TodayJennifer Doudna, PhD, a geneticist and professor at the University of California Berkeley and the Howard Hughes Medical Institute, created CRISPR in collaboration with Emmanuelle Charpentie… Continue reading
In a milestone year, gene therapy finds a place in medicineFairfield Daily RepublicAfter decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene therapies to treat cancer a… Continue reading
Japan TodayIn a milestone year, gene therapy finds a place in medicine – Japan …Japan TodayAfter decades of hope and high promise, this was the year scientists really showed they could doctor DNA to successfully treat diseases. Gene therapies to trea… Continue reading
|
Zach Hartman, PhD Positions For 2018: Oncology And Immunotherapy In Focus
Seeking Alpha Cell therapy is going to be a big factor in 2018, with companies like Gilead and Juno Therapeutics leading the charge. Gene therapies have also been boiling in the kettle in 2017, and we’re almost certain to see some of our first approvals for viral … |
OZY |
CRISPR’s About to Get a Massive Upgrade
OZY Welcome to 2018: Research teams around the world are looking beyond CRISPR, DNA editing tech’s first generation, to the next leaps forward. Those include the potential to transform nucleotides, which could correct mutations, anti-CRISPR proteins that … |